These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18019707)

  • 1. Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients.
    Ichiba M; Yamada S; Ishii K; Gonda K; Murai R; Shimomura T; Saeki T; Kanbe T; Tanabe Y; Yoshida Y; Tsuchiya H; Hoshikawa Y; Kurimasa A; Kishimoto Y; Kawasaki H; Shiota G
    Hepatogastroenterology; 2007 Sep; 54(78):1736-40. PubMed ID: 18019707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients.
    Yano T; Shoji F; Baba H; Koga T; Shiraishi T; Orita H; Kohno H
    Lung Cancer; 2009 Jan; 63(1):111-4. PubMed ID: 18676055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
    Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
    Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people.
    Sakano N; Takahashi N; Wang DH; Sauriasari R; Takemoto K; Kanbara S; Sato Y; Takigawa T; Takaki J; Ogino K
    Free Radic Res; 2009 Feb; 43(2):183-92. PubMed ID: 19204871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.
    Horiike S; Kawanishi S; Kaito M; Ma N; Tanaka H; Fujita N; Iwasa M; Kobayashi Y; Hiraku Y; Oikawa S; Murata M; Wang J; Semba R; Watanabe S; Adachi Y
    J Hepatol; 2005 Sep; 43(3):403-10. PubMed ID: 16023246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
    Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
    Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking status or age impact on urinary 8-hydroxy-2'-deoxyguanosine in electrical and electronic equipment waste dismantling workers].
    Wen S; Gong Y; Li JG; Shi TM; Zhao YF; Xu Y; Wu YN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):474-7. PubMed ID: 19950712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
    Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
    Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary 8-hydroxy-2'-deoxyguanosine excretion in long-distance bus drivers in Taiwan.
    Han YY; Donovan M; Sung FC
    Chemosphere; 2010 May; 79(9):942-8. PubMed ID: 20303570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.
    Pagano G; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Zatterale A; Anak SS; Akisik EE; Beneduce G; Calzone R; De Nicola E; Dunster C; Lloret A; Manini P; Nobili B; Saviano A; Vuttariello E; Warnau M
    Carcinogenesis; 2004 Oct; 25(10):1899-909. PubMed ID: 15192013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients.
    Kuo HW; Chou SY; Hu TW; Wu FY; Chen DJ
    Mutat Res; 2007 Jul; 631(1):62-8. PubMed ID: 17512776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leanness, smoking, and enhanced oxidative DNA damage.
    Mizoue T; Kasai H; Kubo T; Tokunaga S
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):582-5. PubMed ID: 16537720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
    J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
    Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
    Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy preceding stem cell transplantation.
    Bergman V; Leanderson P; Starkhammar H; Tagesson C
    Free Radic Biol Med; 2004 Feb; 36(3):300-6. PubMed ID: 15036349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage.
    Loft S; Fischer-Nielsen A; Jeding IB; Vistisen K; Poulsen HE
    J Toxicol Environ Health; 1993; 40(2-3):391-404. PubMed ID: 8230310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of urinary 8-hydroxy-2'-deoxyguanosine excretion in healthy adults.
    Pilger A; Germadnik D; Riedel K; Meger-Kossien I; Scherer G; Rüdiger HW
    Free Radic Res; 2001 Sep; 35(3):273-80. PubMed ID: 11697126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
    Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
    Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.